ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Santhera Pharmaceuticals Holdings Ltd (PK)

Santhera Pharmaceuticals Holdings Ltd (PK) (SPHDF)

11.70
0.00
(0.00%)
Closed June 22 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
11.70
Bid
11.70
Ask
11.70
Volume
-
0.00 Day's Range 0.00
9.40 52 Week Range 13.35
Market Cap
Previous Close
11.70
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
6,181,292
Dividend Yield
-
PE Ratio
1.32
Earnings Per Share (EPS)
8.86
Revenue
103.41M
Net Profit
54.78M

About Santhera Pharmaceuticals Holdings Ltd (PK)

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Liestal, Che
Founded
1970
Santhera Pharmaceuticals Holdings Ltd (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker SPHDF. The last closing price for Santhera Pharmaceuticals (PK) was $11.70. Over the last year, Santhera Pharmaceuticals (PK) shares have traded in a share price range of $ 9.40 to $ 13.35.

Santhera Pharmaceuticals (PK) currently has 6,181,292 shares outstanding. The market capitalization of Santhera Pharmaceuticals (PK) is $72.32 million. Santhera Pharmaceuticals (PK) has a price to earnings ratio (PE ratio) of 1.32.

SPHDF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260.45411.2511.711.2541111.41423358CS
522.324.46808510649.413.359.465211.18178889CS
156-17.3-59.65517241382931.26.8287920.42876586CS
260-130.5-91.7721518987142.2142.56.8437432.03524756CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AREBAmerican Rebel Holdings Inc
$ 0.76
(152.49%)
371.46M
SHCRSharecare Inc
$ 1.365
(76.27%)
56.33M
NXLNexalin Technologies Inc
$ 1.7499
(59.08%)
57.58M
FUFUBitFuFu Inc
$ 6.1209
(56.95%)
2.5M
SPECSpectaire Holdings Inc
$ 0.50
(47.06%)
65.27M
FLFVFeutune Light Acquisition Corporation
$ 2.5502
(-69.75%)
862.38k
FLFVUFeutune Light Acquisition Corporation
$ 2.75
(-66.83%)
16.5k
RWODRedwoods Acquisition Corporation
$ 2.34
(-60.34%)
155.96k
KAVLKaival Brands Innovations Group Inc
$ 1.23
(-57.14%)
4.92M
RWODURedwoods Acquisition Corporation
$ 3.24
(-56.28%)
1.47k
NVDANVIDIA Corporation
$ 126.57
(-3.22%)
658.13M
AREBAmerican Rebel Holdings Inc
$ 0.76
(152.49%)
371.46M
SIRISirius XM Holdings Inc
$ 2.94
(1.38%)
330.66M
AAPLApple Inc
$ 207.49
(-1.04%)
246.38M
NKLANikola Corporation
$ 0.3466
(5.16%)
193.36M

SPHDF Discussion

View Posts
Renee Renee 12 months ago
SPHDF one for 10 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
👍️0
beebob77 beebob77 10 years ago
SPHDF is one step ahead in DMD submission!

Check out Santhera Pharm with a 100 - 400% opportunity:
In comparision to the peers PTC or SRPT we have a fair value of 180USD/share without NDA submission.

Expected Upcoming Milestones
Q4 2014 – Start Phase I CALLISTO study for omigapil in CMD.
H1 2015 – CHMP decision on Raxone as an LHON treatment.
H1 2015 – NDA and MAA submission for Raxone/Catena as a DMD treatment.
H1 2015 – NDA submission for Raxone/Catena for LHON.
H2 2015 – Commercial launch of Raxone for LHON in EU.
Q1 2016 – Commercial launch of Raxone/Catena for DMD in US and EU.
H1 2016 – Commercial launch of Raxone/Catena for LHON in US.


DMD - Market Opportunity
The various price points are, on average, between $300,000 and $500,000 per patient per year. If you consider this in terms of the target population, the company estimates there would be about 2,000 patients in the U.S. that would be amenable to Eteplirsen. This translates into a $600 million to $1 billion market opportunity in the U.S. alone. The EU could add 9,000 additional patients as well.

LifeSci Capital Coverage: link

ValualationLAB Analysis: link
👍️0
stocktrademan stocktrademan 10 years ago
$SPHDF recent news/filings

bullish

## source: finance.yahoo.com

Fri, 15 Aug 2014 05:15:00 GMT ~ Santhera Receives CHF 13.4 Million Through Sale of Treasury Shares

[GlobeNewswire] - LIESTAL, Switzerland -- Santhera Pharmaceuticals (SIX:SANN) today announced that it completed the sale of 200,000 registered shares of common stock at an average price of CHF 66.85 per share, a 4.3% premium ...

read full: http://finance.yahoo.com/news/santhera-receives-chf-13-4-051500317.html
*********************************************************


$SPHDF charts



basic chart ## source: eoddata.com



$SPHDF company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/SPHDF/company-info
Ticker: $SPHDF
OTC Market Place: OTC Pink Current
CIK code: not found
Company name: Santhera Pharmaceuticals Holdings Ltd.
Company website: http://www.santhera.com
Incorporated In: Switzerland


$SPHDF share structure

## source: otcmarkets.com

Market Value: $255,314,992 a/o Aug 18, 2014
Shares Outstanding: 3,660,430 a/o Aug 29, 2011
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$SPHDF extra dd links

Company name: Santhera Pharmaceuticals Holdings Ltd.
Company website: http://www.santhera.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=SPHDF+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=SPHDF+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=SPHDF+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/news - http://finance.yahoo.com/q/h?s=SPHDF+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/SPHDF/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=SPHDF+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/SPHDF
DTCC (dtcc.com): http://search2.dtcc.com/?q=Santhera+Pharmaceuticals+Holdings+Ltd.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Santhera+Pharmaceuticals+Holdings+Ltd.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Santhera+Pharmaceuticals+Holdings+Ltd.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.santhera.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.santhera.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.santhera.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/SPHDF
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=SPHDF&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=SPHDF
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=SPHDF+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=SPHDF+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=SPHDF
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=SPHDF
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=SPHDF+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/SPHDF/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=SPHDF+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/SPHDF.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=SPHDF
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/SPHDF
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/SPHDF
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/SPHDF:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=SPHDF
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=SPHDF



$SPHDF DD Notes ~ http://www.ddnotesmaker.com/SPHDF
👍️0